A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors
A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors
Active, not recruiting · NCT07749703 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors | Histologically or Cytologically Confirmed Advanced Solid Tumors | Active, not recruiting | Phase 1 | 2026-08-11 | NCT07749703 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Simcere Pharmaceutical Co., Ltd. | 24 |
| Shanghai Xianwei Medical Technology Co., Ltd. | 5 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 85 |
| Shandong Cancer Hospital and Institute | Jinan | China | 8 |
| Shanghai Pulmonary Hospital | Shanghai | China | 23 |
| The First Affiliated Hospital of University of Science and Technology of China | Hefei | China | 16 |
| The First Hospital of China Medical University | Shenyang | China | 42 |
| Zhejiang Cancer Hospital | Hangzhou | China | 84 |